Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yu Fan

Q4 2023 · 13F-HR

Yu Fanholdings as filed

Filed 2024-02-14 · accession 0000950123-24-002149

$20.0M
Reported value
4
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
14179K101CRGXCARGO THERAPEUTICS$19.0M95.4%822,171CommonSOLE
14843C105CSTLCASTLE BIOSCIENCES$485,6152.43%22,503CommonSOLE
786700104SGMTSAGIMET BIOSCIENCES$309,9701.55%57,190CommonSOLE
747324101PYXSPYXIS ONCOLOGY$124,7450.63%69,303CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.